Arrowhead Research | Utile Per Azione

Fiscal Calendario Efettivo Consenso Precedente Data
FY2024Q2 Mar/2024 -1.02 -0.47 0.45 May/09 2024
FY2024Q1 Dec/2023 -1.24 -0.80 -0.39 Feb/06 2024
FY2023Q4 Sep/2023 -1.92 -0.61 -0.81 Nov/29 2023
FY2023Q3 Jun/2023 -0.96 -0.73 -0.68 Aug/07 2023
FY2023Q2 Mar/2023 0.45 -0.68 0.41 May/02 2023
FY2023Q1 Dec/2022 -0.39 0.16 -0.6 Feb/06 2023
FY2022Q4 Sep/2022 -0.81 -0.29 -0.61 Nov/28 2022
FY2022Q3 Jun/2022 -0.68 -0.65 -0.29 Aug/04 2022
FY2022Q2 Mar/2022 0.41 -0.10 -0.26 May/10 2022
FY2022Q1 Dec/2021 -0.6 -0.49 -0.2 Feb/02 2022
FY2021Q4 Sep/2021 -0.61 -0.28 -0.48 Nov/22 2021
FY2021Q3 Jun/2021 -0.29 -0.23 -0.13 Aug/05 2021

Eps Cambiamento Data
Agios Pharmaceuticals USD -1.45 0.27 2024-03
Alnylam Pharmaceuticals USD -0.16 0.94 2024-03
Arrowhead Research USD -1.02 0.22 2024-03
Incyte USD 0.64 0.42 2024-03
Ionis Pharmaceuticals USD -0.98 0.92 2024-03
Ligand Pharmaceuticals USD 1.2 0.18 2024-03
Merck USD 2.07 2.04 2024-03
Moderna USD -3.07 3.62 2024-03
Novartis USD 1.8 0.27 2024-03
Sarepta Therapeutics USD 0.73 0.26 2024-03
TG Therapeutics USD -0.07 0.03 2024-03
Ultragenyx Pharmaceutical USD -2.03 0.51 2024-03
Vertex Pharmaceuticals USD 4.76 0.56 2024-03
Xencor USD -1.11 0.8 2024-03



Arrowhead Research Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.